182 related articles for article (PubMed ID: 14632429)
1. Prediction of anti-HIV-1 activity of a series of tetrapyrrole molecules.
Vanyúr R; Héberger K; Jakus J
J Chem Inf Comput Sci; 2003; 43(6):1829-36. PubMed ID: 14632429
[TBL] [Abstract][Full Text] [Related]
2. Modelling of cytotoxicity data (CC50) of anti-HIV 1-[5-chlorophenyl) sulfonyl]-1H-pyrrole derivatives using calculated molecular descriptors and Levenberg-Marquardt artificial neural network.
Arab Chamjangali M
Chem Biol Drug Des; 2009 Apr; 73(4):456-65. PubMed ID: 19291106
[TBL] [Abstract][Full Text] [Related]
3. Prediction of cytotoxicity data (CC(50)) of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives by artificial neural network trained with Levenberg-Marquardt algorithm.
Arab Chamjangali M; Beglari M; Bagherian G
J Mol Graph Model; 2007 Jul; 26(1):360-7. PubMed ID: 17350867
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationship study on the anti-HIV-1 activity of novel 6-naphthylthio HEPT analogs.
Riahi S; Pourbasheer E; Dinarvand R; Ganjali MR; Norouzi P
Chem Biol Drug Des; 2009 Aug; 74(2):165-72. PubMed ID: 19549086
[TBL] [Abstract][Full Text] [Related]
5. Variable selection and interpretation in structure-affinity correlation modeling of estrogen receptor binders.
Marini F; Roncaglioni A; Novic M
J Chem Inf Model; 2005; 45(6):1507-19. PubMed ID: 16309247
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity relationship studies on 2-amino-6-arylsulfonylbenzonitriles as human immunodeficiency viruses type 1 reverse transcriptase inhibitors using descriptors obtained from substituents and whole molecular structures.
Hemmateenejad B; Sabet R; Fassihi A
Chem Biol Drug Des; 2009 Oct; 74(4):405-15. PubMed ID: 19691465
[TBL] [Abstract][Full Text] [Related]
7. Linear and nonlinear quantitative structure-activity relationship modeling of the HIV-1 reverse transcriptase inhibiting activities of thiocarbamates.
Goodarzi M; Freitas MP; Vander Heyden Y
Anal Chim Acta; 2011 Oct; 705(1-2):166-73. PubMed ID: 21962359
[TBL] [Abstract][Full Text] [Related]
8. Support vector machines: development of QSAR models for predicting anti-HIV-1 activity of TIBO derivatives.
Darnag R; Mostapha Mazouz EL; Schmitzer A; Villemin D; Jarid A; Cherqaoui D
Eur J Med Chem; 2010 Apr; 45(4):1590-7. PubMed ID: 20110136
[TBL] [Abstract][Full Text] [Related]
9. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
10. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
Cormanich RA; Goodarzi M; Freitas MP
Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
Nandi S; Vracko M; Bagchi MC
Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
[TBL] [Abstract][Full Text] [Related]
12. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors.
Katritzky AR; Kuanar M; Dobchev DA; Vanhoecke BW; Karelson M; Parmar VS; Stevens CV; Bracke ME
Bioorg Med Chem; 2006 Oct; 14(20):6933-9. PubMed ID: 16908166
[TBL] [Abstract][Full Text] [Related]
13. Probabilistic neural network model for the in silico evaluation of anti-HIV activity and mechanism of action.
Vilar S; Santana L; Uriarte E
J Med Chem; 2006 Feb; 49(3):1118-24. PubMed ID: 16451076
[TBL] [Abstract][Full Text] [Related]
14. QSAR study on the antinociceptive activity of some morphinans.
Ramírez-Galicia G; Garduño-Juárez R; Hemmateenejad B; Deeb O; Deciga-Campos M; Moctezuma-Eugenio JC
Chem Biol Drug Des; 2007 Jul; 70(1):53-64. PubMed ID: 17630995
[TBL] [Abstract][Full Text] [Related]
15. Neural networks: Accurate nonlinear QSAR model for HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
J Chem Inf Comput Sci; 2003; 43(4):1200-7. PubMed ID: 12870912
[TBL] [Abstract][Full Text] [Related]
16. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
Leonard JT; Roy K
Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
[TBL] [Abstract][Full Text] [Related]
17. In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives.
Vilar S; Estrada E; Uriarte E; Santana L; Gutierrez Y
J Chem Inf Model; 2005; 45(2):502-14. PubMed ID: 15807516
[TBL] [Abstract][Full Text] [Related]
18. QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters.
Gayen S; Debnath B; Samanta S; Jha T
Bioorg Med Chem; 2004 Mar; 12(6):1493-503. PubMed ID: 15018923
[TBL] [Abstract][Full Text] [Related]
19. Benchmarking of linear and nonlinear approaches for quantitative structure-property relationship studies of metal complexation with ionophores.
Tetko IV; Solov'ev VP; Antonov AV; Yao X; Doucet JP; Fan B; Hoonakker F; Fourches D; Jost P; Lachiche N; Varnek A
J Chem Inf Model; 2006; 46(2):808-19. PubMed ID: 16563012
[TBL] [Abstract][Full Text] [Related]
20. QSARs and activity predicting models for competitive inhibitors of adenosine deaminase.
Sadat Hayatshahi SH; Abdolmaleki P; Ghiasi M; Safarian S
FEBS Lett; 2007 Feb; 581(3):506-14. PubMed ID: 17250831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
